Hafrun Fridriksdottir
2019
In 2019, Hafrun Fridriksdottir earned a total compensation of $4.4M as Executive Vice President, Global Research and Development at Teva Pharmaceutical Industries, a 27% decrease compared to previous year.
Compensation breakdown
| Bonus | $837,500 |
|---|---|
| Non-Equity Incentive Plan | $734,832 |
| Salary | $720,000 |
| Stock Awards | $1,899,988 |
| Other | $185,405 |
| Total | $4,377,725 |
Fridriksdottir received $1.9M in stock awards, accounting for 43% of the total pay in 2019.
Fridriksdottir also received $837.5K in bonus, $734.8K in non-equity incentive plan, $720K in salary and $185.4K in other compensation.
Rankings
In 2019, Hafrun Fridriksdottir's compensation ranked 2,635th out of 13,971 executives tracked by ExecPay. In other words, Fridriksdottir earned more than 81.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,635 out of 13,971 | 81st |
Division Manufacturing | 948 out of 5,701 | 83rd |
Major group Chemicals And Allied Products | 307 out of 2,200 | 86th |
Industry group Drugs | 248 out of 1,886 | 87th |
Industry Pharmaceutical Preparations | 181 out of 1,398 | 87th |
Source: SEC filing on April 22, 2020.
Fridriksdottir's colleagues
We found six more compensation records of executives who worked with Hafrun Fridriksdottir at Teva Pharmaceutical Industries in 2019.
2019
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2019
Carlo de Notaristefani
Teva Pharmaceutical Industries
Former Executive Vice President, Global Operations
2019
Michael McClellan
Teva Pharmaceutical Industries
Chief Financial Officer
2019
Brendan O'Grady
Teva Pharmaceutical Industries
Executive Vice President, North America Commercial
2019
Gianfranco Nazzi
Teva Pharmaceutical Industries
Executive Vice President, International Markets Commercial
2019
Eli Kalif
Teva Pharmaceutical Industries